PCSK9 Inhibitors: Are We on the Verge of a Breakthrough? [electronic resource]
Producer: 20160517Description: 590-601 p. digitalISSN:- 1532-6535
- Animals
- Antibodies, Monoclonal -- adverse effects
- Anticholesteremic Agents -- adverse effects
- Biomarkers -- blood
- Cardiovascular Diseases -- etiology
- Cholesterol, LDL -- blood
- Diffusion of Innovation
- Drug Discovery -- trends
- Humans
- Hypercholesterolemia -- blood
- Molecular Targeted Therapy -- trends
- Proprotein Convertase 9
- Proprotein Convertases -- antagonists & inhibitors
- Risk Factors
- Serine Endopeptidases -- genetics
- Serine Proteinase Inhibitors -- adverse effects
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.